Search for: "United States v. Bristol"
Results 201 - 220
of 229
Sort by Relevance
|
Sort by Date
17 Aug 2009, 10:44 am
(Franklin, MA; John Mcdonough, President) Bay State Network, Inc. [read post]
1 Jul 2009, 1:24 am
iStock_000001565285Medium.jpg Defendant's drug distribution conspiracy conviction reversed because trial judge failed to probe the extent that other jury members were exposed to errant juror's Internet search results, in United States v. [read post]
20 Mar 2009, 2:05 am
United States, 880 F.2d 84, 86-87 (8th Cir. 1989).Kansas: Savina v. [read post]
27 Feb 2009, 7:00 am
(The IP Factor) Uganda Anti-counterfeits conference held in Kampala (Afro-IP) United Kingdom IP rights in the Court of Appeal, but not as we know them...: Office of Communications v Information Commissioner (IPKat) IPO review of practice before Patent Tribunal (PatLit) Employee inventor compensation: an expensive pastime? [read post]
12 Dec 2008, 10:55 pm
We find that the district court properly exercised its discretion to impose a sentence without a presentence report under Federal Rule of Criminal Procedure 32(c)(1)(A)(ii) and United States Sentencing Guidelines Manual § 6A1.1(a)(2). [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
4 Aug 2008, 6:30 am
Bristol City Sheriff's Office, 2008 U.S. [read post]
24 Jun 2008, 12:15 pm
The company does, however, offer ADRs in the United States. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
21 Feb 2008, 10:21 am
Yesterday, the United States Supreme Court established new law regarding the confrontation clause of the United States Constitution. [read post]
25 Dec 2007, 10:32 am
Stewart v. [read post]
4 Dec 2007, 6:33 pm
Pharmaceutical Resources and Par Pharmaceuticals v. [read post]
24 Nov 2007, 7:11 am
This list was assembled by United Cerebral Palsy. [read post]
18 Nov 2007, 7:48 am
The guide was compiled by United Cerebral Palsy. [read post]
